首页> 外文会议>Annual meeting exposition of the Controlled Release Society >Inclusion of Factor XIIIa inhibitors as a new approach to the treatment of catheter and medical device related infections
【24h】

Inclusion of Factor XIIIa inhibitors as a new approach to the treatment of catheter and medical device related infections

机译:将因子XIIIA抑制剂作为治疗导管和医疗器械相关感染的新方法

获取原文

摘要

The present research is focused on the development of polymeric coatings for polyurethane central venous catheters (CVC) and other medical implant devices with the aim of incorporating a novel group of FXIIIa inhibitors into the polymeric coatings of catheters. FXIIIa coating of catheter and other medical implants could offer new perspectives in preventing catheter associated staphylococcal infection and a lower incidence of thrombotic occlusion.
机译:本研究专注于聚合物涂层的聚合物涂层,用于聚氨酯中心静脉导管(CVC)和其他医用植入装置,其目的是将新的FXIIIa抑制剂组掺入导管的聚合物涂层中。 FXIIIA的导管和其他医疗植入物可以在预防导管相关的葡萄球菌感染和血栓形成闭塞的较低发病率方面提供新的视角。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号